Intractable & Rare Diseases Research
Online ISSN : 2186-361X
Print ISSN : 2186-3644
ISSN-L : 2186-3644

This article has now been updated. Please use the final version.

Cardiac manifestations of idiopathic pulmonary fibrosis
Abhinav AgrawalIsha VermaVarun ShahAbhishek AgarwalRutuja R Sikachi
Author information
JOURNAL FREE ACCESS Advance online publication

Article ID: 2016.01023

Details
Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, parenchymal disease of the lung with an estimated prevalence of 14-43 per 100,000. Patient usually presents with coughing and exertional dyspnea, which can lead to acute respiratory failure. IPF has been associated with various co-morbidities such as lung cancer, emphysema, obstructive sleep apnea (OSA), GERD and multiple cardiovascular consequences. The cardiovascular manifestations of IPF include pulmonary hypertension, heart failure, coronary artery disease, cardiac arrhythmias & cardiac manifestations of drugs used to treat IPF. This review will outline evidence of the association between IPF and cardiovascular conditions and attempt to provide insights into the underlying pathophysiology. We also discuss the impact of these cardiovascular diseases on patients with IPF including increased morbidity and mortality.

Content from these authors
© 2016 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
feedback
Top